Valuation: Star Scientific, Inc.

Market Cap 2L 1L 1L 1L 2L 1.46Cr 2L 15.07L 6L 76.62L 6L 6L 2.42Cr P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 2Cr 1.79Cr 1.65Cr 1.49Cr 2.79Cr 190Cr 2.84Cr 20Cr 7.89Cr 100Cr 7.51Cr 7.35Cr 315.19Cr EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.19%+11.31%+67.86%+150.58% 1,22400Cr
-0.73%+3.56%+44.51%+85.81% 66TCr
+1.41%+3.24%+29.22%+107.83% 51TCr
+0.42%+3.20%+54.15%+67.18% 39TCr
+2.18%+2.93%+73.30%+45.62% 36TCr
+1.12%+4.52%+35.30%+58.08% 30TCr
+6.96%+8.86%+11.27%+36.62% 27TCr
+1.15%+6.09%+59.59%+77.06% 25TCr
+3.06%+9.38%+44.11%+119.47% 21TCr
Average +1.73%+5.61%+46.59%+83.14% 46.41TCr
Weighted average by Cap. +1.17%+6.35%+50.91%+98.22%

Financials

2014 2015
Net sales - -
Net income -3.85Cr -3.45Cr -3.17Cr -2.88Cr -5.37Cr -365.72Cr -5.47Cr -38Cr -15Cr -192.38Cr -14Cr -14Cr -606.7Cr -68.45L -61.3L -56.39L -51.09L -95.51L -65Cr -97.29L -6.72Cr -2.7Cr -34Cr -2.57Cr -2.51Cr -107.82Cr
Net Debt -45T -40.3T -37.07T -33.59T -62.79T -42.73L -63.96T -4L -2L -22.48L -2L -2L -70.88L 1.99Cr 1.78Cr 1.64Cr 1.48Cr 2.77Cr 188.54Cr 2.82Cr 20Cr 7.83Cr 99Cr 7.45Cr 7.29Cr 312.78Cr
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-